Linvesta Emp 25/5mg (14 Tablet / Pack)

Prescription dual-action tablet used to optimize glycemic control in adults with type 2 diabetes.

PKR 1000.00

You save: PKR 0

Quantity:

SKU: LINVESTA_EMP_255MG_14_TABLET_PACK

Category: Tablets & Capsules

Linvesta Emp 25/5mg Tablets are a prescription-only combination medicine indicated to control high blood sugar profiles in adults diagnosed with type 2 diabetes mellitus. It leverages dual actions to lower glucose reabsorption via renal pathways while simultaneously enhancing natural pancreatic insulin responses. This comprehensive approach effectively manages glycemic control and mitigates structural long-term cardiovascular risks.

Purpose

Used to lower blood sugar profiles and reduce cardiovascular risks in type 2 diabetes mellitus.

Ingredients

Empagliflozin 25mg, Linagliptin 5mg

Warnings

Monitor regularly for signs of severe urinary tract infections or urosepsis. Discontinue use immediately if symptoms of acute pancreatitis occur. Risk of dehydration or volume depletion when combined with concurrent diuretics. Not authorized for use in type 1 diabetes or diabetic ketoacidosis.